logo

For the Inventor, By the Inventor

Tampa, FL, United States of America

H. Lee Moffitt Cancer Center and Research Institute, Inc.


USPTO Granted Patents = 291



Trademarks = 53

Forward Citations = 589

Loading Chart...
Loading Chart...

289 inventors (with patents filed for the assignee):

goldMedal Said M Sebti (39 out of 109 patents)

silverMedal Nicholas James Lawrence (36 out of 39 patents)

bronzeMedal Harshani Lawrence (29 out of 29 patents)

4.  Robert J Gillies (22 out of 25 patents)

5.  Alan F List (18 out of 22 patents)

6.  Mark L McLaughlin (15 out of 24 patents)

7.  David L Morse (14 out of 19 patents)

8.  Timothy J Yeatman (12 out of 16 patents)

9.  Marco L Davila (12 out of 12 patents)

10.  Sabrina A Gonzalez Blohm (10 out of 12 patents)

11.  James J Doulgeris (10 out of 15 patents)

12.  Frank D Vrionis (10 out of 12 patents)

13.  Kamran Aghayev (10 out of 12 patents)

14.  Dung-Tsa Chen (10 out of 10 patents)

15.  Josef Vagner (9 out of 13 patents)


Core Competencies:
Radiomics
Molecular Imaging
Peptidomimetics
Tumor-Infiltrating Lymphocytes
Oncolytic Virus Therapy
Chimeric Antigen Receptors
CAR T-Cells
MicroRNA Assays
Theranostics
Immunotherapy
Cancer Treatment
Protein-Protein Interaction Inhibitors

291 patents:

1. 12491187 - Use of MCT1 inhibitors to enhance insulin sensitivity (2025-12-09),
2. 12462406 - Systems and methods for slide image alignment (2025-11-04),
3. 12453786 - Radiomics-based treatment decision support for lung cancer (2025-10-28),
4. 12433549 - Molecular imaging of the cochlea (2025-10-07),
5. 12415832 - B-catenin/B-cell Lymphoma 9 protein-protein interaction inhibiting peptidomimetics (2025-09-16),
6. 12410479 - Microrna assay for detection and management of pancreatic cancer precursors (2025-09-09),
7. 12406772 - Systems and methods for predicting individual patient response to radiotherapy using a dynamic carrying capacity model (2025-09-02),
8. 12391676 - BRD4-JAK2 inhibitors (2025-08-19),
9. 12383604 - Bioengineering tertiary lymphoid structures using chitosan-based hydrogels (2025-08-12),
10. 12344642 - Variant survivin vaccine for treatment of myeloma (2025-07-01),
11. 12319685 - Small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors (2025-06-03),
12. 12291724 - Tumor-infiltrating lymphocytes for adoptive cell therapy (2025-05-06),
13. 12269899 - Peptidomimetic inhibitors of β-catenin/Tcf protein-protein interaction (2025-04-08),
14. 12264184 - DAP12 constructs and their use to enhance DC vaccines and immunotherapies (2025-04-01),
15. 12263147 - Treatment of STK11-loss cancers (2025-04-01),
H. Lee Moffitt Cancer Center and Research Institute, Inc. is a renowned nonprofit cancer research and treatment center located in Tampa, Florida, United States. Moffitt Cancer Center is the only National Cancer Institute-designated Comprehensive Cancer Center in the state of Florida. It focuses on all aspects of cancer care, including research, prevention, diagnosis, and treatment. With state-of-the-art facilities and a dedicated team of healthcare professionals, Moffitt Cancer Center strives to contribute to the prevention and cure of cancer.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

...
291 Patents

#4 in Tampa, FL

#31 in Florida

#1,445 in US

#2,969 in the World

...
Tampa, FL, United States of America

H. Lee Moffitt Cancer Center and Research Institute, Inc.

Forward Citations = 589

289 inventors:

goldMedal Said M Sebti (39 out of 109 patents)

silverMedal Nicholas James Lawrence (36 out of 39 patents)

bronzeMedal Harshani Lawrence (29 out of 29 patents)

4.  Robert J Gillies (22 out of 25 patents)

5.  Alan F List (18 out of 22 patents)

Please report any incorrect information to support@idiyas.com
Loading…